However, data also shows NHS dentists are delivering more treatments.

Roche announced that the Avastin study RIBBON-1 met its primary endpoint of increasing the time women with breast cancer lived without their disease advancing (known as progression-free survival) compared to chemotherapy alone, as determined by the treating physicians. RIBBON-1 is

Nplate will address an unmet medical need for thousands of patients in the European Union as it is a unique treatment option that increases platelet production and avoids immune suppression in adult chronic ITP patients," said Willard Dere, M.D., senior

More than 11 million Americans, the vast majority former or current smokers, are living with so-called COPD, marked by the potentially fatal, lung-diminishing conditions of emphysema and chronic bronchitis. The inhalers in question greatly relieve such symptoms as shortness of

Eduardo, age 58, was diagnosed with HIV in 1988, and by 1995 he was dying from HIV-related illnesses. He was told to "Take a vacation and enjoy what's left of your life." Somehow, Eduardo survived and was still struggling to

Dr. Sacks has dedicated 33 years of taking care of Kaiser Permanente patients and children with diabetes. For his years of extensive research in diabetes and quality of treatment, Dr. Sacks was recognized by the ADA for his work in

As many as 10,000 participants are expected to walk the five kilometre route, according to the event organisers, Imperial College London Diabetes Centre (ICLDC).

The positive outcome reported today was from the double-blind, randomized placebo-controlled portion of a phase 3 clinical study.

The dose-finding study was a randomized, placebo-controlled, double-blind, multicenter, multinational clinical trial that evaluated the efficacy and safety of four different doses (1, 2, 5 or 10 mg BID) of preladenant compared to placebo in the treatment of patients with

The Fitness Industry Association (FIA) yesterday ( Wednesday November 26) announced its aims to engage one million more people - people who are not already 'activity literate' - with a new national campaign, More Active 4 Life.

PARADYM CRT is designed to allow more flexibility in the management of cardiac resynchronization and anti-tachyarrhythmia therapy in heart failure patients, thanks to the unique Brady-Tachy Overlap™ (BTO) feature.

Demand for wide viewing angle and wide field of vision displays has increased in high performance monitoring equipment. Medical imaging applications such as ultrasonic based diagnostic and computed tomography (CT) scanning systems require highly consistent optical performance and accurate image

The agreement covers additional research to be conducted by Compugen and provides Merck Serono with an option to exclusively license the novel peptide for worldwide development and commercialization. Compugen also announced that CGEN-855 and supporting experimental data are the subject

Having found records dating back to the 1920s for dogs and the 19th century for humans and thoroughbreds, Denny looked to see whether there were any clear trends; had any of the species' performances already levelled off? Plotting the annual

The NHS Information Centre report reveals that 19,348,000 adult patients were seen by an NHS dentist in the 24 months up to 30 June 2008, compared to 20,348,000 in the 24 months up to 31 March 2006. The same period

The positive opinion from the CHMP, the committee responsible for the scientific assessment of new medicinal products, will be reviewed by the European Commission, which then has authority to approve medicines for use throughout the European Union.

miRNAs represent an attractive target for scientists who study CVD. Several investigations proved that they play a pivotal role, still to be defined, in cardiogenesis, cancer and in the regulation of complex processes. They are RNA molecules, but they do

The CHMP recommended approval of ustekinumab for adults with moderate to severe plaque psoriasis who have failed to respond to, have a contraindication to, or are intolerant to other systemic therapies including ciclosporin, methotrexate and PUVA (a light sensitising medication,